Novartis India Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis India Limited with three other
companies in this sector in India:
Caplin Point Laboratories Limited
sales of 5.40 billion Indian Rupees [US$77.79 million]
of which 100%
Neuland Laboratories Limited
(5.27 billion Indian Rupees [US$76.00 million]
Astrazeneca Pharma India Ltd
(5.71 billion Indian Rupees [US$82.28 million]
Novartis India Limited reported sales of 5.64 billion Indian Rupees (US$81.26 million)
March of 2018.
decrease of 14.1%
versus 2017, when the company's sales were 6.56 billion Indian Rupees.